ArticleBMJ paediatrics open2026
Temporal changes in bronchopulmonary dysplasia severity distribution associated with evolving respiratory practices in very preterm infants.
Article in BMJ paediatrics open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate temporal changes in respiratory management practices and bronchopulmonary dysplasia (BPD) severity in infants born before 32 weeks of gestation over a 9-year period.
designRetrospective cohort study.
settingTertiary neonatal intensive care unit. PATIENTS: Infants born before 32 weeks of gestation and admitted between January 2017 and December 2025. EXPOSURE: Birth during one of three predefined clinical eras: pre-COVID (2017-2019), COVID (2020-2022) and post-COVID following relocation to an expanded neonatal intensive care unit (2023-2025).
main outcome measuresBPD severity at 36 weeks of postmenstrual age (PMA), mortality before hospital discharge, and the composite outcome of death before hospital discharge or BPD at 36 weeks of PMA. Associations between study era and respiratory outcomes were evaluated using multivariate logistic regression.
resultsA total of 1259 infants were included. Respiratory management practices changed across study eras. High-flow nasal cannula exposure increased from 43.7% in era 1 to 70.6% in era 3 (p<0.001), while duration of non-invasive respiratory support increased from 4 to 11 days (p<0.001). Less invasive surfactant administration was introduced predominantly during era 3, and postnatal corticosteroid exposure increased from 16.5% to 36.4% (p<0.001). BPD incidence increased across eras (25.2%, 30.9% and 37.7%; p<0.001), primarily driven by grade 2 disease, whereas grade 3 BPD and mortality remained stable. Compared with era 1, infants in era 3 had higher adjusted odds of moderate-to-severe BPD (adjusted OR 3.29, 95% CI 2.15 to 5.05; p<0.001) and the composite outcome of death before hospital discharge or BPD at 36 weeks of PMA (adjusted OR 2.08, 95% CI 1.47 to 2.94; p<0.001).
conclusionsRespiratory management practices evolved over time and were accompanied by increased moderate BPD without corresponding increases in severe BPD or mortality. These findings suggest that evolving respiratory support practices and contemporary BPD definitions may influence the observed distribution of BPD severity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.